eisai-europe-limited

eisai-europe-limited

Partenaire YouScribe

84 publication(s)
2 628 consultation(s)
Toutes ses publications
https://img.uscri.be/pth/f4a397c6cb238741db3bd6d55e6520528d35d816
Zonegran® (zonisamida), bien tolerado en el ... eisai-europe-limited

Zonegran® (zonisamida), bien tolerado enZonegran® (zonisamida), bien tolerado en el tratamiento prolongado de los niños que

https://img.uscri.be/pth/37bfa02c2166d3fbd12c0d8d09c2ef72728e471e
Zonegran® (zonisamide) chez les enfants ... eisai-europe-limited

Zonegran® (zonisamide) chez les enfantsZonegran® (zonisamide) chez les enfants souffrant de crises d'epilepsie partielles :

https://img.uscri.be/pth/7a9c45a423a491df3278f13f6d5e942eacd5689c
Zonegran® (Zonisamide) Well Tolerated in ... eisai-europe-limited

Zonegran® (Zonisamide) Well Tolerated inZonegran® (Zonisamide) Well Tolerated in Long-term Treatment of Children with Partial

https://img.uscri.be/pth/f8c56216aa8fef1b12227e677299e536771d571d
Halaven® (Eribulin) Now Commercially Available ... eisai-europe-limited

Halaven® (Eribulin) Now CommerciallyHalaven® (Eribulin) Now Commercially Available in Lebanon for the Treatment of Metastatic

https://img.uscri.be/pth/9b470f345921065dfb1d66769b63b586624a06a8
Eisai to Collaborate with Liverpool School of ... eisai-europe-limited

Eisai to Collaborate with Liverpool SchoolEisai to Collaborate with Liverpool School of Tropical Medicine and University of

https://img.uscri.be/pth/943b825e646b29e0ae37dce64820b6449dac99e7
Zonegran® (Zonisamide) Approved for Use in ... eisai-europe-limited

Zonegran® (Zonisamide) Approved forZonegran® (Zonisamide) Approved for Use in Children and Adolescents by Scottish Medicines

https://img.uscri.be/pth/25074ddb25ce3138b27a5322eeb8465bc4928ec0
El Ministerio de Sanidad español autoriza la ... eisai-europe-limited

El Ministerio de Sanidad español autorizaEl Ministerio de Sanidad español autoriza la financiación de Zonegran® (zonisamida)

https://img.uscri.be/pth/5c0b612774d4410e60340032b2154fd908ae5716
Epilepsy Treatment Zonegran® (Zonisamide) ... eisai-europe-limited

Epilepsy Treatment Zonegran®Epilepsy Treatment Zonegran® (Zonisamide) Receives Reimbursement in Spain as Monotherapy for Adults

https://img.uscri.be/pth/b6fc46e32d587e085c8f878382576a0a6fb58b78
Feu vert en Espagne pour le remboursement de ... eisai-europe-limited

Feu vert en Espagne pour leFeu vert en Espagne pour le remboursement de Zonegran® (zonisamide) dans deux nouvelles indications

https://img.uscri.be/pth/2778fa66876b61a6f7fa8420120143aaa98747d6
Fycompa® (Perampanel) to be Resubmitted Early ... eisai-europe-limited

Fycompa® (Perampanel) to beFycompa® (Perampanel) to be Resubmitted Early to German Federal Joint Committee (G-BA) for

https://img.uscri.be/pth/927031d736c905f73be528a32a01dbe2cdb73ec8
L'essai select de phase III du lenvatinib ... eisai-europe-limited

L'essai select de phase III du lenvatinibL'essai select de phase III du lenvatinib satisfait à son critère principal:

https://img.uscri.be/pth/4275457218fc3498be0f7bc6d407b450d6dad406
El ensayo SELECT de fase III de lenvatinib ... eisai-europe-limited

El ensayo SELECT de fase III de lenvatinibEl ensayo SELECT de fase III de lenvatinib cumple con el criterio principal de

https://img.uscri.be/pth/bdfa69a9043982838b90597add0d0006f4bc6bef
Once-daily Epilepsy Treatment Zebinix® ... eisai-europe-limited

Once-daily Epilepsy Treatment Zebinix®Once-daily Epilepsy Treatment Zebinix® (Eslicarbazepine Acetate) Now Available with Full

https://img.uscri.be/pth/39e246812e3dd60061f449d57ee9aa15f7552903
Phase III Select Trial of Lenvatinib Meets ... eisai-europe-limited

Phase III Select Trial of Lenvatinib MeetsPhase III Select Trial of Lenvatinib Meets Primary Endpoint of Improved Progression

https://img.uscri.be/pth/63743a17c3e61513d7bba4467ee4813a21b29316
Zonegran® (zonisamide) Reimbursed in ... eisai-europe-limited

Zonegran® (zonisamide) Reimbursed inZonegran® (zonisamide) Reimbursed in Switzerland as Monotherapy Treatment for Adults With

https://img.uscri.be/pth/af1523a718f065c5495ec634340d11c298891e22
New First-in-class Epilepsy Treatment Fycompa® ... eisai-europe-limited

New First-in-class Epilepsy TreatmentNew First-in-class Epilepsy Treatment Fycompa® (perampanel) Launches in Spain PR Newswire

https://img.uscri.be/pth/cb77039ec34281861f838572e1bfb904a57c406e
Lanzamiento en España de Fycompa® (perampanel), ... eisai-europe-limited

Lanzamiento en España de Fycompa®Lanzamiento en España de Fycompa® (perampanel), un nuevo tratamiento primero en su clase para

https://img.uscri.be/pth/2691f52754dfc538c30dc565aa8344c6ee541c08
European Commission Grants Orphan Drug Status ... eisai-europe-limited

European Commission Grants OrphanEuropean Commission Grants Orphan Drug Status to Eisai's Amatuximab for the Treatment of

https://img.uscri.be/pth/c3f12f1b9b494a1ccbe478c7acd1f4b997044d6d
Life-extending Metastatic Breast Cancer ... eisai-europe-limited

Life-extending Metastatic Breast CancerLife-extending Metastatic Breast Cancer Treatment Now Available in the Republic of

https://img.uscri.be/pth/9e5519f8906f6fbcad30753b6e288b640af6f1c1
Innovative Metastatic Breast Cancer Treatment ... eisai-europe-limited

Innovative Metastatic Breast CancerInnovative Metastatic Breast Cancer Treatment Halaven® (Eribulin) Recieves Reimbursement

https://img.uscri.be/pth/cd2e2894556284fe7dda9c6f4118d01f104e0605
Inovelon® (Rufinamide) Oral Suspension ... eisai-europe-limited

Inovelon® (Rufinamide) Oral SuspensionInovelon® (Rufinamide) Oral Suspension Formulation Launched in Portugal PR Newswire

https://img.uscri.be/pth/6c96f5b502609f55d3350ee36e513a5525345465
Eisai's Named Patient Access Programme for ... eisai-europe-limited

Eisai's Named Patient Access ProgrammeEisai's Named Patient Access Programme for Fycompa® (perampanel) Available from 1 January

https://img.uscri.be/pth/a6eb17cc557df3d3d758723a3069f2378c343f84
Eisai anuncia nueva colaboración con Esteve ... eisai-europe-limited

Eisai anuncia nueva colaboración conEisai anuncia nueva colaboración con Esteve para la promoción del fármaco contra la

https://img.uscri.be/pth/44de0ba5e2db5c418700fdc5a1800976acaf783a
Eisai Announces New Partnership with Esteve to ... eisai-europe-limited

Eisai Announces New Partnership withEisai Announces New Partnership with Esteve to Promote Anti-epilepsy Drug Zonegran®